As a major pharmaceutical company that is constantly innovating and developing new treatments, Eli Lilly (NYSE: LLY) is ...

Eli Lilly (LLY 0.86%) and Novo Nordisk (NVO -1.53%) have competed for decades. They're both leaders in the areas of insulin ...

President-elect Donald Trump set two tables for a dinner party this month with his choice for Health and Human Services ...

When managing complex chronic dermatologic diseases, efforts to incorporate alternative treatments can add efficacy, patient ...

With drugs like Novo Nordisk's Wegovy becoming household names over the last couple of years, it's no surprise that there are ...

Mazisotine is a small molecule commercialized by Eli Lilly and Co, with a leading Phase II program in Diabetic Neuropathic Pain.

Eloralintide is a synthetic peptide commercialized by Eli Lilly and Co, with a leading Phase II program in Obesity.

Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business ...

Indiana’s Governor Eric Holcomb says he’s reflecting on his time as Governor now that it’s about to come to an end next month ...

Cowboy boots, an Ohio River scene, former First Dog Henry: all were key components of outgoing Indiana Gov. Eric Holcomb’s ...